Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women between 20 and 80 years old
- People who have been diagnosed with uterine (endometrial) cancer confirmed by a tissue sample, and have not yet received any treatment for it
- People whose cancer is one of several specific types, including endometrioid, mucinous, serous, clear cell, undifferentiated, dedifferentiated, mesonephric adenocarcinoma, mesonephric-like adenocarcinoma, carcinosarcoma, or mixed type
- People whose cancer falls within certain grading categories (FIGO grade 1, 2, or 3)
- People whose cancer is thought to be at an early stage (presumed FIGO stage I or II)
- People who are planned to have a keyhole (laparoscopic) or robotic surgery to remove the uterus and nearby lymph nodes
- People whose largest pelvic or abdominal lymph node measures 15 mm or less on the short side, as seen on an MRI scan
- People who are in reasonably good general health, able to carry out daily activities with little or no difficulty (ECOG performance status 0–2)
- People rated as low surgical risk by their anaesthetist (ASA physical status 0–2)
- People whose blood test results meet the required levels for white blood cells, platelets, kidney function, and liver function (confirm with trial site for specific values)
- People who have voluntarily agreed to take part and signed a consent form
Who may not be able to join:
- People whose cancer is thought to have spread more widely (presumed FIGO stage III or IV)
- People whose cancer is of a neuroendocrine tumour type
- People who have another disease affecting their lymphatic system
- People who already have lymphoedema (swelling caused by fluid build-up) in the lower legs, groin, or surrounding area
- People who have previously had surgery to remove pelvic or abdominal lymph nodes
- People who have previously had radiotherapy or combined chemotherapy and radiotherapy to the abdomen or pelvis
- People who have previously received chemotherapy for a cancer in the abdomen or pelvis
- People who have had or been treated for another cancer within the past five years, with the exception of certain skin cancers or early-stage cervical, stomach, or bladder lesions (confirm specific exceptions with trial site)
- People with serious or poorly controlled ongoing health conditions, or existing conditions that have led to complications
- People with a known allergy to indocyanine green (a dye used during surgery)
- People who are pregnant or currently breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +82-2-3010-3646
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The 3-year disease-free survival (3-year DFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.